Activity value 81International Buyer&Supplier,Last transaction date:
2026-07-20Address: corporate campussarkhej-dholka road, bhtahmedabad-382210 india
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for cadila pharmaceuticals ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 792 transactions, with a transaction quantity of 214117963.68 and a transaction weight of 252729.
Product description
SHIPPER_DESCRIPTION (CELECOXIB CAPSULES,GLY BURIDE TABLETS,NEBIVOLOL TABLETS,VENLAFAXINE ER TAB,OLMESARTAN MEDOXOMIL TABS USP,NATEGLINIDE TABLETS, USP) - HSCD_DESCRIPTION (MEDIC AMENTS, N.O.S., DOSAGE) PLEASE NOTE - QUANTITY AND DESCRIPTION OF THECARGO ARE BASED ON THE SHIPPER S LOAD AND CO UNT. OCEAN CARRIER HAS NO KNOWLEDGE, INFORMATION, OR REASON TO BELIEVE OR SUSPECT THAT TH E INFORMATION FURNISHED BY THE SHIPPER IS INCOMPLETE, INACCURATE, OR FALSE Expand
Product description
SHIPPER_DESCRIPTION (PHARMACEUTICAL MEDICIN ES) - HSCD_DESCRIPTION (MEDICAMENTS, N.O.S. , DOSAGE) PLEASE NOTE - QUANTITY AND DESCRIPTION OF THECARGO ARE BASED ON THE SHIPPER S LOAD AND CO UNT. OCEAN CARRIER HAS NO KNOWLEDGE, INFORMATION, OR REASON TO BELIEVE OR SUSPECT THAT TH E INFORMATION FURNISHED BY THE SHIPPER IS INCOMPLETE, INACCURATE, OR FALSE Expand
Product description
SHIPPER_DESCRIPTION (PHARMACEUTICAL MEDICIN ES VERAPAMIL HYDROCHLO. EXTREL.USP 240 100T) - HSCD_DESCRIPTION (MEDICAMENTS, N.O.S., DO SAGE) PLEASE NOTE - QUANTITY AND DESCRIPTION OF THECARGO ARE BASED ON THE SHIPPER S LOAD AND CO UNT. OCEAN CARRIER HAS NO KNOWLEDGE, INFORMAT ION, OR REASON TO BELIEVE OR SUSPECT THAT TH E INFORMATION FURNISHED BY THE SHIPPER IS INCOMPLETE, INACCURATE, OR FALSE Expand
Trade date
2026/06/18
B/L No.
61841163441
Suppliers
cadila pharmaceuticals ltd.
Buyers
ambica international
5eurimex pharma
francesupplier,they trade on 2026-02-06
11342.30%
>
+View All
Products
Total 1352
ProductsTransactionsPerDetail
bat 259443.97%>
pharmaceutical raw material 88515%>
r pharm 87614.85%>
mg tablet 79813.53%>
raw material 74012.54%>
+View All
Hscode rank
Total 863
HSCode NameTransactionsPerDetail
HS 3004909996416.34%>
HS 3004903962110.53%>
HS 300490792995.07%>
HS 292219902494.22%>
HS 293339291722.92%>
+View All
Trading Area
Total 159
AreaTransactionsPerDetail
ethiopia601912.21%>
sri lanka21654.39%>
other19413.94%>
nepal16753.40%>
mauritius16503.35%>
+View All
Port statistics
Total 104
Port NameTransactionsPerDetail
ahemdabad icd insbi61007020.43%>
ahemdabad air acc inamd4798216.19%>
mundra38317.77%>
sahar air cargo acc inbom422524.57%>
raxaul inrxlb20244.11%>
+View All
cadila pharmaceuticals ltd. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as bat,pharmaceutical raw material,r pharm.
According to the 52wmb.com global trade database, as of 2026-07-20, the company has completed 49297 international trades,
with its main trading regions covering ethiopia,sri lanka,other etc.
The core products include HS30049099,HS30049039,HS30049079 etc,
often transported via ahemdabad icd insbi6,port ahemdabad air acc inamd4, port mundra etc,
and its main trading partners are .cadila pharmaceuticals ethiop,sunshine heathcare lanka ltd.,life care suppliers pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on cadila pharmaceuticals ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.